Skip to main content
Premium Trial:

Request an Annual Quote

AlphaGene Names Schechter as New President and CEO

Premium

WOBURN, Mass.--The bioinformatics company AlphaGene has named Alan Schechter as its new president and CEO, replacing George Scheele, who will remain as AlphaGene's chairman of the board and chief scientific officer.

Schechter was previously president and CEO of Applied Carotenoid Sciences Inc., a biopharmaceutical device R&D company. AlphaGene is focused on developing technologies for gene and protein discovery to accelerate drug development.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.